Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and

Dongyan Shao1, Ziyang Lian1, Yichao Di1

  • 11Key Laboratory for Space Bioscience and Biotechnology, School of Life Sciences, Northwestern Polytechnical University, 127 Youyi West Road, Xi'an, 710072 Shaanxi China.

NPJ Science of Food
|July 16, 2019
PubMed

Insights

Dietary compounds can inhibit atherosclerosis (AS) by targeting specific microRNAs (miRNAs) involved in cholesterol metabolism and inflammation. This review explores dietary compounds, miRNAs, and their roles in AS therapy.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Atherosclerosis (AS) is a major cause of cardiovascular disease, initiated by cholesterol-laden macrophages in artery walls.
  • Dysregulated cholesterol influx/efflux in macrophages and inflammation significantly promote AS development.
  • MicroRNAs (miRNAs) play crucial roles in regulating macrophage cholesterol metabolism and inflammation in AS.

Purpose of the Study:

  • To review current literature on dietary compounds targeting miRNAs for atherosclerosis (AS) therapy.
  • To investigate the mechanisms by which dietary compounds influence macrophage cholesterol metabolism and inflammation via miRNAs.
  • To identify challenges and guide future research in this therapeutic area.

Main Methods:

  • Literature review of studies investigating dietary compounds, miRNAs, and atherosclerosis.
  • Analysis of miRNA targets involved in cholesterol metabolism (e.g., ABCA1, ABCG1) and inflammation (e.g., NF-κB, Nrf2, PI3K/AKT pathways).
  • Identification of specific miRNAs (e.g., miR-19b, miR-378, miR-10b, miR-33a/b, miR-155, miR-146a) modulated by dietary compounds.

Main Results:

  • Dietary compounds inhibit AS by targeting miRNAs involved in cholesterol metabolism (miR-19b, miR-378, miR-10b, miR-33a/b) and inflammation (miR-155, miR-146a).
  • While cholesterol-related miRNA targets vary among compounds, miR-155 is a common target in inflammation signaling.
  • Key receptors (ABCA1, ABCG1) and signaling pathways (NF-κB, Nrf2, PI3K/AKT) are modulated by miRNAs in macrophages.

Conclusions:

  • Dietary compounds offer a promising therapeutic strategy for atherosclerosis by modulating specific miRNA pathways.
  • Targeting miRNAs involved in both cholesterol metabolism and inflammation presents a multifaceted approach to AS treatment.
  • Further research is needed to overcome existing challenges and optimize dietary compound-mediated miRNA therapies for AS.

Related Concept Videos

Dietary Connections01:23

Dietary Connections

In biological systems, most metabolic pathways are interconnected. The cellular respiration processes that convert glucose to ATP—such as glycolysis, pyruvate oxidation, and the citric acid cycle—tie into those that break down other organic compounds. As a result, various foods—from apples to cheese to guacamole—end up as ATP. In addition to carbohydrates, food also contains proteins and lipids—such as cholesterol and fats. All of these organic compounds are used...
61.5K
Inflammation01:38

Inflammation

Overview
61.8K
Controlled-Potential Coulometry: Electrolytic Methods01:17

Controlled-Potential Coulometry: Electrolytic Methods

Controlled-potential coulometry, also known as potentiostatic coulometry, employs a three-electrode system in which the working electrode's potential is precisely regulated using a potentiostat. Platinum working electrodes are utilized for positive potentials, while mercury pool electrodes are favored for extremely negative potentials. The platinum counter electrode is separated from the analyte using a membrane or salt bridge to avoid interference in the analysis.
The chosen potential...
682
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
343
What is Metabolism?00:52

What is Metabolism?

Overview
131.3K